• search

Aurobindo Pharma purchases US FDA Compliant facility

Written by: Staff
|

New Delhi, July 7 (UNI) Aurobindo Pharma today announced it has acquired a US FDA compliant cGMP facility in Dayton, New Jersey.

The facility, spread over 20 acres of free hold land is located in the heart of Princeton Life Sciences Corridor in the state of New Jersey and is comprised of 100,000 square feet of fully integrated state of the art R&D, formulation manufacturing and distribution facilities with potential for future expansion.

This facility will serve as the Company's US head quarters.

Aurobindo Pharma Chairman Ramprasad Reddy said this purchase reinforces company's commitment to serve US market in an effective manner.

The company has recently concluded zero per cent, foreign currency convertible bonds issue of 200 million dollar.

UNI DKS RP DB2121

For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more